Sterling Capital Management’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-625
Closed -$3.39K 3288
2025
Q2
$3.39K Buy
625
+247
+65% +$1.23K ﹤0.01% 2717
2025
Q1
$1.31K Sell
378
-257
-40% -$1.25K ﹤0.01% 2725
2024
Q4
$6.53K Buy
635
+572
+908% +$7.13K ﹤0.01% 2343
2024
Q3
$854 Buy
+63
New +$781 ﹤0.01% 2619

Other funds holding THRD

Sterling Capital Management's THRD Position: Q3 2025 in Review

Sterling Capital Management sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 625 shares — an estimated $3.39K sold.

Sterling Capital Management first reported a position in THRD in Q3 2024 and held it in 4 quarters. The position peaked at $6.53K in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Sterling Capital Management reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Sterling Capital Management sold 625 Third Harmonic Bio shares in Q3 2025, an estimated $3.39K.
  • Sterling Capital Management first reported a position in Third Harmonic Bio in Q3 2024 and held it in 4 quarters.
  • Sterling Capital Management's Third Harmonic Bio position peaked at $6.53K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Sterling Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.